CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Open-market buy 10% owner bought 1,408,468 shares at $6.41 ($9,021,801)
- 4 Open-market buy Chief Financial Officer bought 85,000 shares at $5.79 ($492,150)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market buy Director bought 10,000 shares at $8.54 ($85,400)
- 4 Open-market buy Director bought 20,000 shares at $9.05 ($181,000)
- 4 Open-market buy Chief Operating Officer bought 230,789 shares at $8.66 ($1,998,633)
- S-3ASR Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 8-K Event Results of operations · Regulation FD disclosure
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 10 of 17 · 325 filings